Thursday, September 5, 2019
8:00 PM - 9:30 PM ET
PharmCon Webinar Studio (freeCE.com)
1.5 Contact Hour(s)
Cardiovascular disease (CVD) remains the leading cause of death in the United States. The American Heart Association estimates that 33% of men aged 40 to 59 and nearly 33% of women aged 60 years and older have high triglyceride levels. Most goals for CVD prevention or management involve raising HDL levels while lowering LDL and triglyceride levels to recommended ranges. However, more and more research is showing that triglyceride levels are an independent risk factor for CVD, greatly increasing the chances of heart disease and stroke. This activity will offer pharmacists a greater understanding of the new cholesterol guidelines and review CV outcomes trials to improve management of patients at risk of ASCVD events.
Indepth review of ASCVD cardiovascular trials - printed slides maybe useful if using a phone or small screen.
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.
Professor of Pharmacy Practice; Creighton University
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.